HK18194A - Substituted benzamide derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same - Google Patents

Substituted benzamide derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same Download PDF

Info

Publication number
HK18194A
HK18194A HK181/94A HK18194A HK18194A HK 18194 A HK18194 A HK 18194A HK 181/94 A HK181/94 A HK 181/94A HK 18194 A HK18194 A HK 18194A HK 18194 A HK18194 A HK 18194A
Authority
HK
Hong Kong
Prior art keywords
compound
amino
methyl
formula
halogen
Prior art date
Application number
HK181/94A
Other languages
German (de)
English (en)
French (fr)
Inventor
Tatsuya Kon
Shiro Kato
Toshiya Morie
Kazunori Ohno
Katsuhiko Hino
Tadahiko Karasawa
Naoyuki Yoshida
Original Assignee
Dainippon Sumitomo Pharma Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Sumitomo Pharma Co., Ltd. filed Critical Dainippon Sumitomo Pharma Co., Ltd.
Publication of HK18194A publication Critical patent/HK18194A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D267/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02Seven-membered rings
    • C07D267/08Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/10Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
HK181/94A 1986-04-30 1994-03-03 Substituted benzamide derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same HK18194A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10155286 1986-04-30
JP31509086 1986-12-31

Publications (1)

Publication Number Publication Date
HK18194A true HK18194A (en) 1994-03-11

Family

ID=26442419

Family Applications (1)

Application Number Title Priority Date Filing Date
HK181/94A HK18194A (en) 1986-04-30 1994-03-03 Substituted benzamide derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same

Country Status (18)

Country Link
US (1) US4870074A (enExample)
EP (1) EP0243959B1 (enExample)
KR (1) KR870010030A (enExample)
AR (1) AR242953A1 (enExample)
AU (1) AU592177B2 (enExample)
CA (1) CA1291135C (enExample)
CZ (1) CZ284687B6 (enExample)
DE (1) DE3781195T2 (enExample)
DK (1) DK175281B1 (enExample)
ES (1) ES2043617T3 (enExample)
FI (1) FI87776C (enExample)
GR (1) GR3005934T3 (enExample)
HK (1) HK18194A (enExample)
HU (1) HU198193B (enExample)
NZ (1) NZ220120A (enExample)
PH (1) PH24049A (enExample)
SK (1) SK289787A3 (enExample)
SU (1) SU1597101A3 (enExample)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2640139A1 (fr) * 1988-12-14 1990-06-15 Delagrange Laboratoires Application de benzamides substitues comme gastromoteurs
US5395832A (en) * 1991-02-15 1995-03-07 Hokuriku Seiyaku Co., Ltd. Benzamide derivatives
TW213460B (enExample) * 1991-02-15 1993-09-21 Hokuriku Pharmaceutical
US5864039A (en) * 1994-03-30 1999-01-26 Yoshitomi Pharmaceutical Industries, Ltd. Benzoic acid compounds and use thereof as medicaments
KR970702247A (ko) * 1994-03-30 1997-05-13 고야 마사시 벤조산 화합물 및 이들의 약제로서의 용도(benzoic acid compound and use thereof as medicine)
KR100446099B1 (ko) * 1995-05-23 2004-11-10 얀센 파마슈티카 엔.브이. (2-모르폴리닐메틸)벤즈아미드유도체
JP2001064177A (ja) * 1999-08-16 2001-03-13 Schering Ag ベンズアミド誘導体を有効成分とする製剤
KR20030031198A (ko) 2000-09-29 2003-04-18 글락소 그룹 리미티드 염증 질환 치료용 모르폴린-아세트아미드 유도체
ATE286897T1 (de) * 2000-11-28 2005-01-15 Smithkline Beecham Plc Morpholinderivate als antagonisten an orexinrezeptoren
JP4829417B2 (ja) * 2001-03-26 2011-12-07 明夫 乾 インスリン抵抗性改善薬
AU2002356418A1 (en) * 2001-10-08 2003-04-22 Sun Pharmaceutical Industries Limited An antispasmodic agent spaced drug delivery system
GB0208158D0 (en) * 2002-03-28 2002-05-22 Glaxo Group Ltd Novel compounds
GB0207447D0 (en) * 2002-03-28 2002-05-08 Glaxo Group Ltd Novel compounds
GB0207449D0 (en) * 2002-03-28 2002-05-08 Glaxo Group Ltd Novel compounds
HUP0201980A3 (en) * 2002-06-13 2008-06-30 Richter Gedeon Nyrt Process for preparing a benzamide derivative and intermediates thereof
JP4740740B2 (ja) * 2003-12-09 2011-08-03 大日本住友製薬株式会社 薬物含有粒子および該粒子を含む固形製剤
US8138204B2 (en) * 2004-01-07 2012-03-20 Aryx Therapeutics, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
EP1704146B1 (en) 2004-01-07 2010-04-14 Aryx Therapeutics Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US8524736B2 (en) 2004-01-07 2013-09-03 Armetheon, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
EP1801108B9 (en) * 2004-09-08 2013-11-20 Mitsubishi Tanabe Pharma Corporation Morpholine compounds for the treatment of inflammations
TWI391380B (zh) * 2005-06-23 2013-04-01 Array Biopharma Inc 製備苯并咪唑化合物之方法
ES2436100T3 (es) * 2005-08-31 2013-12-27 Armetheon, Inc. Métodos sintéticos y productos intermedios para compuestos estereoisoméricos útiles para el tratamiento de trastornos del sistema nervioso central y gastrointestinal
US20090042926A1 (en) * 2005-12-20 2009-02-12 Jason Imbriglio Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
KR100750593B1 (ko) * 2006-03-16 2007-08-20 동우신테크 주식회사 치환된 벤즈아미드 유도체의 제조방법
US20080085915A1 (en) * 2006-06-23 2008-04-10 Cyrus Becker Compounds and methods for the treatment of gastrointestinal and central nervous system disorders
WO2008131259A1 (en) 2007-04-19 2008-10-30 Concert Pharmaceuticals Inc. Deuterated morpholinyl compounds
CN101402633A (zh) * 2007-09-11 2009-04-08 上海恒瑞医药有限公司 苯甲酰胺类衍生物、其制备方法及其在医药上的用途
KR101612137B1 (ko) 2008-02-13 2016-04-12 다이닛본 스미토모 세이야꾸 가부시끼가이샤 구강 내 붕괴정
TWI423967B (zh) * 2008-02-21 2014-01-21 Dainippon Sumitomo Pharma Co 醯胺衍生物及含有其之醫藥組合物
EP2465495A4 (en) 2009-08-11 2013-01-23 Dainippon Sumitomo Pharma Co TABLET WITH FAST DECOMPOSITION IN THE MOUTH AND TWO OR MORE TYPES OF PARTICLES
WO2011107903A1 (en) 2010-03-04 2011-09-09 Ranbaxy Laboratories Limited Highly pure mosapride citrate dihydrate and processes for its preparation
BR112013019942B1 (pt) 2011-02-25 2022-01-11 Yuhan Corporation Uso de composto ou de seu sal farmaceuticamente aceitável, composição farmacêutica, compostos ou seus sais farmaceuticamente aceitáveis e respectivos processos de preparação
KR101657616B1 (ko) 2013-05-24 2016-09-19 주식회사유한양행 피리미딘 고리를 포함하는 바이사이클릭 유도체 및 그의 제조방법
TWI794171B (zh) 2016-05-11 2023-03-01 美商滬亞生物國際有限公司 Hdac抑制劑與pd-l1抑制劑之組合治療
TWI808055B (zh) 2016-05-11 2023-07-11 美商滬亞生物國際有限公司 Hdac 抑制劑與 pd-1 抑制劑之組合治療
CN111349052B (zh) * 2020-04-07 2021-02-12 福建海西新药创制有限公司 一种枸橼酸莫沙必利的合成方法
CN114560822B (zh) * 2020-11-27 2024-05-28 鲁南制药集团股份有限公司 一种莫沙必利的二羧酸晶体
CN114591260B (zh) * 2020-12-05 2025-07-11 鲁南制药集团股份有限公司 一种莫沙必利有机酸盐
CN119241463A (zh) * 2024-10-22 2025-01-03 吉林修正药业新药开发有限公司 一种枸橼酸莫沙必利杂质化合物及其制备方法
CN119241464A (zh) * 2024-10-22 2025-01-03 吉林修正药业新药开发有限公司 一种枸橼酸莫沙必利杂质化合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH451142A (de) * 1965-01-19 1968-05-15 Sandoz Ag Verfahren zur Herstellung neuer basisch substituierter Benzoesäureamide
US4029786A (en) * 1972-08-11 1977-06-14 Imperial Chemical Industries Limited Morpholine derivatives for treating depression
US4323503A (en) * 1976-08-04 1982-04-06 Societe D'etudes Scientifiques Et Industrielles De L'ile-De-France Substituted 2,3-alkylene di (oxy) benzamides and derivatives
US4210754A (en) * 1977-02-01 1980-07-01 Hoffmann-La Roche Inc. Morpholino containing benzamides
US4692445A (en) * 1983-04-29 1987-09-08 Rorer Pharmaceutical Corporation Bicyclic benzenoid aminoalkylene ethers and thioethers, pharmaceutical compositions and use
FR2575158B1 (fr) * 1984-12-20 1987-10-02 Pf Medicament Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
JPH0390274A (ja) * 1989-08-28 1991-04-16 Furukawa Alum Co Ltd Al又はAl合金の気相ろう付法

Also Published As

Publication number Publication date
AU7227587A (en) 1987-11-05
FI87776B (fi) 1992-11-13
FI871828A7 (fi) 1987-10-31
CZ284687B6 (cs) 1999-02-17
ES2043617T3 (es) 1994-01-01
NZ220120A (en) 1989-06-28
CZ289787A3 (cs) 1998-11-11
SU1597101A3 (ru) 1990-09-30
FI87776C (fi) 1993-02-25
HUT45514A (en) 1988-07-28
AR242953A1 (es) 1993-06-30
EP0243959A1 (en) 1987-11-04
AU592177B2 (en) 1990-01-04
DK175281B1 (da) 2004-08-09
SK279058B6 (sk) 1998-06-03
GR3005934T3 (enExample) 1993-06-07
HU198193B (en) 1989-08-28
DK218787D0 (da) 1987-04-29
US4870074A (en) 1989-09-26
DE3781195T2 (de) 1993-02-18
FI871828A0 (fi) 1987-04-27
DE3781195D1 (de) 1992-09-24
EP0243959B1 (en) 1992-08-19
SK289787A3 (en) 1998-06-03
DK218787A (da) 1987-10-31
PH24049A (en) 1990-03-05
KR870010030A (ko) 1987-11-30
CA1291135C (en) 1991-10-22

Similar Documents

Publication Publication Date Title
EP0243959B1 (en) Substituted benzamide derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
JPH05140149A (ja) 縮合複素環誘導体
EP0529386B1 (en) Dibenz[B,F][1,4]oxazepin-11(10H)-ones for multidrug resistance reversing agents
HK1005029B (en) Dibenz [b,f] [1,4] oxazepin-11 (10h)-ones for multidrug resistance reversing agents
WO2005000821A1 (en) Tachykinin receptor antagonists
US7687509B2 (en) Pyrimidinecarboxamide derivatives
KR20000005505A (ko) 피페리딘 및 피롤리딘
SK116394A3 (en) Substituted phenylcarbamates and ureas
EP0567090B1 (en) Benzoxazepine derivatives as cholinesterase inhibitors
JPH0354937B2 (enExample)
EP0726898B1 (en) Phenylindole compounds
US5618827A (en) Substituted phenylcarbamates and phenylureas, their preparation and their use as 5-HT antagonists
US4812565A (en) Fused aromatic oxazepinones, thiazepinones, diazepinones and sulfur analogs thereof
EP0529395A2 (en) Benzamide multidrug resistance reversing agents
KR950008530B1 (ko) 치환된 벤즈아미드 유도체, 그 제조방법 및 이를 함유하는 약학적 조성물
US4604388A (en) Fused aromatic oxazepinones, thiazepinones, diazepinones and sulfur analogs thereof in a method of counteracting histamine
KR20030036834A (ko) 5-페닐벤질아민 화합물, 그의 제법 및 그의 합성 중간체
IE904461A1 (en) Muscarinic receptor antagonists
SK137597A3 (en) 1-£'omega'-(3,4-dihydro-2-naphthalenyl)alkyl| cyclic amine derivatives, process for producing the same, and medicinal composition containing the same
US4810795A (en) Certain 2,5 and 2,5,6-di- and tri-substituted nicotinic acid intermediates
HK1013817B (en) Phenylindole compounds
HK1019744A1 (en) Indoline derivatives useful as 5-ht-2c receptor antagonists

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20070428